Literature DB >> 33618597

Machine learning in asthma research: moving toward a more integrated approach.

Sara Fontanella1, Alex Cucco1, Adnan Custovic1.   

Abstract

Introduction: Big data are reshaping the future of medicine. The growing availability and increasing complexity of data have favored the adoption of modern analytical and computational methodologies in every area of medicine. Over the past decades, asthma research has been characterized by a shift in the way studies are conducted and data are analyzed. Motivated by the assumptions that 'data will speak for themselves', hypothesis-driven approaches have been replaced by data-driven hypotheses-generating methods to explore hidden patterns and underlying mechanisms. However, even with all the advancement in technologies and the new important insight that we gained to understand and characterize asthma heterogeneity, very few research findings have been translated into clinically actionable solutions.Areas covered: To investigate some of the fundamental analytical approaches adopted in the current literature and appraise their impact and usefulness in medicine, we conducted a bibliometric analysis of big data analytics in asthma research in the past 50 years.Expert opinion: No single data source or methodology can uncover the complexity of human health and disease. To fully capitalize on the potential of 'big data', we will have to embrace the collaborative science and encourage the creation of integrated cross-disciplinary teams brought together around technological advances.

Entities:  

Keywords:  Asthma; big data; data analytics; machine learning; statistics

Year:  2021        PMID: 33618597     DOI: 10.1080/17476348.2021.1894133

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  1 in total

1.  Data-driven research on eczema: Systematic characterization of the field and recommendations for the future.

Authors:  Ariane Duverdier; Adnan Custovic; Reiko J Tanaka
Journal:  Clin Transl Allergy       Date:  2022-06-07       Impact factor: 5.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.